JDMJournal of Diabetes Mellitus2160-5831Scientific Research Publishing10.4236/jdm.2021.115031JDM-113240ArticlesMedicine&Healthcare Our Journey with Type 1 Diabetes for over a Half Century: A Dialogue between Patient Spouse and Her Physician Caregiver LindaSeveridt1LarrySeveridt1*Broadlawns Medical Center, Regional Dean Des Moines University, University of Iowa, Des Moines, Iowa15112021110538839328, September 202115, November 2021 18, November 2021© Copyright 2014 by authors and Scientific Research Publishing Inc. 2014This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/

A personal perspective and a narration by a patient and her Physician spouse caregiver regarding coping with evolution in therapeutic modalities including ongoing changing insulin formulations and insulin administration devices. Narration also encompasses and establishes the utility of the improving glycemic monitoring tools in assisting in attaining desirable glycemic goals.

Insulins Insulin Pumps Glucometer Continuous Glucose Monitoring System (CGMS)Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

Cite this paper

Severidt, L. and Severidt, L. (2021) Our Journey with Type 1 Diabetes for over a Half Century: A Dialogue between Patient Spouse and Her Physician Caregiver. Journal of Diabetes Mellitus, 11, 388-393. https://doi.org/10.4236/jdm.2021.115031

ReferencesThe Diabetes Control and Complications Trial (DCCT) (1986) The DCCT Research Group. Diabetes, 35, 530-545. https://doi.org/10.2337/diab.35.5.530Bradley, R.F., Dolger, H., Forsham, P. and Seltzer, H. (1975) Settling the UGDP Controversy? JAMA, 232, 813-817.Shapiro, J., et al. (2000) Islet Cell Transplantation in Seven Patients with Type I Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen. The New England Journal of Medicine, 343, 230-238. https://doi.org/10.1056/NEJM200007273430401